Ubagai T, Lei K J, Huang S, Mudd S H, Levy H L, Chou J Y
Human Genetics Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Clin Invest. 1995 Oct;96(4):1943-7. doi: 10.1172/JCI118240.
Methionine adenosyltransferase (MAT) is a key enzyme in transmethylation, transsulfuration, and the biosynthesis of polyamines. Genetic deficiency of alpha/beta-MAT causes isolated persistent hypermethioninemia and, in some cases, unusual breath odor or neural demyelination. However, the molecular mechanism(s) underlying this deficiency has not been clearly defined. In this study, we characterized the human alpha/beta-MAT transcription unit and identified several mutations in the gene of patients with enzymatically confirmed diagnosis of MAT deficiency. Site-directed mutagenesis and transient expression assays demonstrated that these mutations partially inactivate MAT activity. These results establish the molecular basis of this disorder and allow for the development of DNA-based methodologies to investigate and diagnose hypermethioninemic individuals suspected of having abnormalities at this locus.
甲硫氨酸腺苷转移酶(MAT)是转甲基作用、转硫作用和多胺生物合成中的关键酶。α/β-MAT基因缺陷会导致孤立性持续性高甲硫氨酸血症,在某些情况下,还会出现特殊的呼吸气味或神经脱髓鞘。然而,这种缺陷背后的分子机制尚未明确。在本研究中,我们对人类α/β-MAT转录单元进行了表征,并在酶学确诊为MAT缺陷的患者基因中鉴定出了几种突变。定点诱变和瞬时表达分析表明,这些突变部分失活了MAT活性。这些结果确立了这种疾病的分子基础,并有助于开发基于DNA的方法来研究和诊断怀疑在此位点存在异常的高甲硫氨酸血症个体。